Dal Bello, Reinaldo
Pasanisi, Justine
Joudinaud, Romane
Duchmann, Matthieu
Pardieu, Bryann
Ayaka, Paolo
Di Feo, Giuseppe
Sodaro, Gaetano
Chauvel, Clémentine
Kim, Rathana http://orcid.org/0000-0002-9987-7237
Vasseur, Loic
Chat, Laureen
Ling, Frank
Pacchiardi, Kim
Vaganay, Camille
Berrou, Jeannig
Benaksas, Chaima
Boissel, Nicolas http://orcid.org/0000-0003-2091-7927
Braun, Thorsten
Preudhomme, Claude
Dombret, Hervé
Raffoux, Emmanuel
Fenouille, Nina
Clappier, Emmanuelle
Adès, Lionel http://orcid.org/0000-0002-9020-8766
Puissant, Alexandre
Itzykson, Raphael http://orcid.org/0000-0003-2139-6262
Funding for this research was provided by:
Gilead Foundation
Association Laurette Fugain (ALF2020-01)
Institut National Du Cancer (PRTK15-125)
Article History
Received: 30 November 2021
Revised: 13 May 2022
Accepted: 7 June 2022
First Online: 24 June 2022
Competing interests
: Ri has received research funding from Oncoethix (now Merck) and Novartis, and honoraria from Abbvie, Astellas, BMS, and Karyopharm. Other authors have no relevant conflict of interest to disclose.